查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2024696

智慧吸入器市場報告：按產品、適應症、分銷管道和地區分類（2026-2034 年）

Smart Inhalers Market Report by Product, Indication (Asthma, Chronic Obstructive Pulmonary Disease ), Distribution Channel, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2025年全球智慧吸入器市場規模達3.621億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到16.419億美元，2026年至2034年的複合年成長率為17.74%。

智慧型吸入器是一種呼吸道吸入器，它可以監測用藥依從性，發送用藥提醒，透過藍牙輕鬆共用訊息，並準確記錄每次用藥的日期、時間和地點。它還可以幫助提高治療依從性，增強患者參與症狀管理的動機和動力，並提供可能影響患者胸部狀況的環境和天氣報告。隨著氣喘和慢性阻塞性肺病（COPD）盛行率的不斷上升，全球對智慧吸入器的需求也不斷成長。

智慧吸入器市場趨勢：

隨著全球空氣污染日益嚴重，慢性呼吸道疾病（CRD）、肺癌、慢性支氣管炎和急性下呼吸道感染疾病（ALRI）的患者數量顯著增加。這是推動市場成長的主要因素之一。此外，由於吸入方法不當或依從性低，傳統吸入器可能無效，從而加重患者病情。然而，智慧吸入器利用其數位化功能，配合行動應用程式監測用藥時間和劑量，可以有效應對患者和醫護人員在疾病管理方面面臨的挑戰。智慧吸入器還可以根據症狀在需要採取特定措施時向患者和臨床醫生發出警報，從而促進患者過渡到更合適的自我護理。此外，智慧吸入器技術的最新進展，例如能夠為使用者提供吸入技巧回饋和計算合適的用藥依從率，也推動了市場的發展。患者對使用智慧吸入器益處的認知不斷提高，預計也將有助於提升整體銷售額和盈利。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球智慧吸入器市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 吸入器
    • 主要部分
      • 乾粉吸入器
      • 定量噴霧吸入器
  • 噴霧器

第7章 市場區隔：依適應症分類

  • 氣喘
  • 慢性阻塞性肺病（COPD）

第8章 市場區隔：依分銷通路分類

  • 醫院藥房
  • 零售藥房
  • 網路商店

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • 3M Company
    • Adherium Limited
    • AptarGroup Inc.
    • AstraZeneca plc
    • Boehringer Ingelheim
    • Cognita Labs
    • GlaxoSmithKline plc
    • Novartis AG
    • OPKO Health Inc.
    • Propeller Health（ResMed）
    • Sensirion AG
    • Teva Pharmaceutical Industries Ltd.
    • Vectura Group Limited（Philip Morris International Inc.）
Product Code: SR112026A5417

The global smart inhalers market size reached USD 362.1 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,641.9 Million by 2034, exhibiting a growth rate (CAGR) of 17.74% during 2026-2034.

Smart inhalers are respiratory inhalers that can monitor adherence, send dosage reminders, offer access to readily shareable information via Bluetooth, and record the time, date and location of each dosage administered accurately. They can also help improve compliance with therapy, increase patient involvement and motivation in controlling symptoms, and provide reports about environmental and weather conditions that may affect their chest. Due to the growing prevalence of asthma and chronic obstructive pulmonary diseases (COPD), there is a rise in the demand for smart inhalers across the globe.

SMART INHALERS MARKET TRENDS:

Due to a rise in air pollution levels worldwide, there is a significant increase in the number of patients with chronic respiratory diseases (CRDs), lung cancer, chronic bronchitis, and acute lower respiratory infections (ALRI). This represents one of the key factors propelling the growth of the market. Moreover, the efficacy of conventional inhalers can be negatively impacted by incorrect inhaler techniques and poor adherence, which may result in the progression of patients' condition. However, smart inhalers can address the challenges of patients and healthcare professionals in the management of these diseases using digital features designed to connect with mobile applications for monitoring medication schedules and subsequent dosing. Additionally, they can alert patients and clinicians when symptoms require specific action and facilitate a shift to better self-care. This, coupled with recent advances in smart inhaler technology, which allow feedback to users on their inhaler technique and the calculation of the correct level of adherence, is driving the market. Besides this, the increasing awareness about the benefits of using smart inhalers among patients is projected to augment the overall sales and profitability.

KEY MARKET SEGMENTATION:

Breakup by Product:

  • Inhalers
  • Dry Powdered Inhaler
  • Metered Dose Inhaler
  • Nebulizers

Breakup by Indication:

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Stores

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

COMPETITIVE LANDSCAPE:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Adherium Limited, AptarGroup Inc., AstraZeneca plc, Boehringer Ingelheim, Cognita Labs, GlaxoSmithKline plc, Novartis AG, OPKO Health Inc., Propeller Health (ResMed), Sensirion AG, Teva Pharmaceutical Industries Ltd. and Vectura Group Limited (Philip Morris International Inc.).

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Smart Inhalers Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Inhalers
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Dry Powdered Inhaler
      • 6.1.2.2 Metered Dose Inhaler
    • 6.1.3 Market Forecast
  • 6.2 Nebulizers
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Asthma
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Chronic Obstructive Pulmonary Disease (COPD)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 3M Company
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Adherium Limited
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 AptarGroup Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 AstraZeneca plc
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Boehringer Ingelheim
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Cognita Labs
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 GlaxoSmithKline plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Novartis AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 OPKO Health Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Propeller Health (ResMed)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Sensirion AG
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12 Teva Pharmaceutical Industries Ltd.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13 Vectura Group Limited (Philip Morris International Inc.)
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Smart Inhalers Market: Major Drivers and Challenges
  • Figure 2: Global: Smart Inhalers Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Smart Inhalers Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 4: Global: Smart Inhalers Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Smart Inhalers Market: Breakup by Indication (in %), 2025
  • Figure 6: Global: Smart Inhalers Market: Breakup by Distribution Channel (in %), 2025
  • Figure 7: Global: Smart Inhalers Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Smart Inhalers (Inhalers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Smart Inhalers (Inhalers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Smart Inhalers (Nebulizers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Smart Inhalers (Nebulizers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Smart Inhalers (Asthma) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Smart Inhalers (Asthma) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Smart Inhalers (Chronic Obstructive Pulmonary Disease (COPD)) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Smart Inhalers (Chronic Obstructive Pulmonary Disease (COPD)) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Smart Inhalers (Hospital Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Smart Inhalers (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Smart Inhalers (Retail Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Smart Inhalers (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Smart Inhalers (Online Stores) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Smart Inhalers (Online Stores) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: North America: Smart Inhalers Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: North America: Smart Inhalers Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: United States: Smart Inhalers Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: United States: Smart Inhalers Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Canada: Smart Inhalers Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Canada: Smart Inhalers Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Asia-Pacific: Smart Inhalers Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Asia-Pacific: Smart Inhalers Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: China: Smart Inhalers Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: China: Smart Inhalers Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Japan: Smart Inhalers Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Japan: Smart Inhalers Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: India: Smart Inhalers Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: India: Smart Inhalers Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: South Korea: Smart Inhalers Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: South Korea: Smart Inhalers Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Australia: Smart Inhalers Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Australia: Smart Inhalers Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Indonesia: Smart Inhalers Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Indonesia: Smart Inhalers Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Others: Smart Inhalers Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Others: Smart Inhalers Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Europe: Smart Inhalers Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Europe: Smart Inhalers Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Germany: Smart Inhalers Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Germany: Smart Inhalers Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: France: Smart Inhalers Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: France: Smart Inhalers Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: United Kingdom: Smart Inhalers Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: United Kingdom: Smart Inhalers Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Italy: Smart Inhalers Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Italy: Smart Inhalers Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Spain: Smart Inhalers Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Spain: Smart Inhalers Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Russia: Smart Inhalers Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Russia: Smart Inhalers Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Others: Smart Inhalers Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Others: Smart Inhalers Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Latin America: Smart Inhalers Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Latin America: Smart Inhalers Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Brazil: Smart Inhalers Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Brazil: Smart Inhalers Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Mexico: Smart Inhalers Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Mexico: Smart Inhalers Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Others: Smart Inhalers Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Others: Smart Inhalers Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Middle East and Africa: Smart Inhalers Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Middle East and Africa: Smart Inhalers Market: Breakup by Country (in %), 2025
  • Figure 70: Middle East and Africa: Smart Inhalers Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Global: Smart Inhalers Industry: SWOT Analysis
  • Figure 72: Global: Smart Inhalers Industry: Value Chain Analysis
  • Figure 73: Global: Smart Inhalers Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Smart Inhalers Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Smart Inhalers Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Smart Inhalers Market Forecast: Breakup by Indication (in Million USD), 2026-2034
  • Table 4: Global: Smart Inhalers Market Forecast: Breakup by Distribution Channel (in Million USD), 2026-2034
  • Table 5: Global: Smart Inhalers Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Smart Inhalers Market: Competitive Structure
  • Table 7: Global: Smart Inhalers Market: Key Players